Delivery Order SPE2DB20D7066-SPE2DB25FC4DJ
Award Date 7/23/25
Potential Completion Date 7/24/25
Potential Value $7.5K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $1,235.01 to AmerisourceBergen Drug Corp for Omnipaque 300 mg/ml vials (10 ml) on July 21, 2025, with an ultimate completion date of July 22, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. Omnipaque is a contrast medium used in medical imaging procedures, reflecting the company's role as a critical...
- This federal contract award is for delivery order SPE2DB22FQ0E8 from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $7,657.50 firm fixed-price contract is for the delivery of Omnipaque 350 mg/mL infusion bottles. AmerisourceBergen, a subsidiary of the parent company Cencora, Inc., holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products...
- The Defense Logistics Agency awarded a delivery order valued at $3,381.60 to AmerisourceBergen Drug Corp for the supply of Omnipaque 350 mg/ml, a contrast media pharmaceutical product in 500ml Pluspak packaging. This firm fixed-price delivery order, awarded on July 24, 2025, represents a non-competitive, non-set-aside procurement with an ultimate completion date of July 25, 2025. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company...
- This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,307.00 firm fixed-price delivery order is for the supply of OMNIPAQUE 350 MG/ML intravenous infusion bottles, 100 mL in size. The contract has an ultimate completion date of September 3, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This is a $6,378.55 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of OMNIPAQUE 350 MG/ML PLUSPAK 500ML, a medical product, with a period of performance through June 17, 2024. This order is part of AmerisourceBergen's $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a primary vehicle for...
- This $3,499.65 firm fixed price delivery order contract was awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Omnipaque 300 mg/mL infusion bottles, a medical product used in federal healthcare programs. The contract is not designated as a set-aside and represents a direct award to AmerisourceBergen, which holds a $999,999,999 Indefinite Delivery Contract (IDC)...
- This is a federal contract award made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,017.76, is for the delivery of Omnipaque 350 mg/ml medical imaging contrast agent. It is a firm fixed-price delivery order with an ultimate completion date of April 26, 2023. The contract was not designated with a set-aside requirement, indicating open competition. AmerisourceBergen holds a...
- This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,483.60 firm-fixed-price contract is for the supply of OMNIPAQUE 300 MG/ML VIAL 10ML, a medical product, with a performance period ending on May 8, 2025. The contract is not set-aside and was awarded on May 7, 2025. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,690.80 firm fixed-price delivery order is for the supply of OMNIPAQUE 350 MG/ML PLUSPAK 500ML, a medical product, with a period of performance through February 5, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,690.80 contract is for the delivery of OMNIPAQUE 350 MG/ML PLUSPAK 500ML, a medical product. The contract has a completion date of June 16, 2025 and is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop...